Not Tagged
eisai pharmaceutical
['solid tumor', 'eisai']
we're working on developing our first antibody-drug conjugate (adc) which is being explored in folate receptor-alpha positive solid tumors. we are proud to share our latest data at #asco22!
At Eisai Oncology Global Medical Affairs, we are driven to pursue innovative solutions to help address cancers with unmet needs.